CLPTM1L Antibody

Size : 50 µL Clone Number: Aliases: C130052I12Rik antibody; Cisplatin resistance related protein 9 antibody; Cisplatin resistance related protein CRR9p antibody; Cisplatin resistance-related protein 9 antibody; Cleft lip and palate transmembrane protein 1 like protein antibody; Cleft lip and palate transmembrane protein 1-like protein antibody; CLP1L_HUMAN antibody; CLPTM1 like antibody; CLPTM1 like protein antibody; CLPTM1-like protein antibody; CLPTM1L antibody; CRR9 antibody; CRR9p antibody; DKFZp666M1010 antibody; DKFZp761M2324 antibody; FLJ14400 antibody; FLJ32533 antibody; MGC36304 antibody; OTTHUMP00000220655 antibody; RGD1307896 antibody Product Type: Polyclonal Antibody Immunogen Species: Homo sapiens (Human) UniProt ID: Q96KA5 Immunogen: Synthetic peptide of Human CLPTM1L Host: Rabbit Reactivity: Human Tested Applications: ELISA, IHC; ELISA: 1: 1000-1: 5000, IHC: 1: 50-1: 200 Background: Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein), also known as cisplatin resistance-related protein 9 (CRR9p), is a protein that in humans is encoded by the CLPTM1L gene. CRR9p is associated with cisplatin-induced apoptosis. CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL. Clonality: Polyclonal Isotype: IgG Purification Method: Antigen affinity purification Conjugate: Non-conjugated Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Form: Liquid Stroage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names: CLPTM1L Research Areas: Cell biology